OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Director BRANCACCIO JOHN P
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
OKYO Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer CERRONE GABRIELE M
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Shah Keeren
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Director Simon Willy Jules
OKYO Pharma | 3: Initial statement of beneficial ownership of securities
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer JACOB GARY S
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Director Denoyer Bernard
No Data